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RESEARCH ARTICLE Open Access
A systematic review and meta-analysis of
vertical transmission route of HIV in
Ethiopia
Aklilu Endalamaw1*, Amare Demsie1, Setegn Eshetie2 and Tesfa Dejenie Habtewold3,4
Abstract
Background: The burden of mother-to-child transmission rate of HIV is high and risk factors are common in
Ethiopia. This systematic review and meta-analysis intended to provide the pooled estimation of mother-to-child
transmission rate and its risk factors in Ethiopia.
Methods: We searched PubMed, Google Scholar, EMBASE and Web of Science electronic databases for all available
references. We included observational studies including case-control, cohort, and cross-sectional studies. The search
was further limited to studies conducted in Ethiopia and publish in English. Heterogeneity was checked using the I2
statistic. Egger’s test and the funnel plot were used to assess publication bias. A meta-analysis using a weighted inverse
variance random-effects model was performed.
Results: A total of 18 studies with 6253 individuals were included in this systematic review and meta-analysis. Of these,
14 studies with 4624 individuals were used to estimate the prevalence. The estimated pooled prevalence of mother-to-
child transmission of HIV was 11.4% (95% CI = 9.1–13.7). The pooled adjusted odds ratio (AOR) of mother-to-child
transmission of HIV for the infants from rural area was 3.8 (95% CI = 1.4 to 6.3), infants delivered at home was
3.2 (95% CI = 1.2 to 5.2), infant didn’t take antiretroviral prophylaxis was 5.8 (95% CI = 1.5 to 10.3), mother didn’t take
antiretroviral prophylaxis was 6.1 (95% CI = 2.5 to 9.6), mothers didn’t receive PMTCT intervention was 5.1 (95% CI = 1.6, 8.6),
and on mixed feeding was 4.3 (95% CI = 1.8 to 6.7).
Conclusions: This systematic review and meta-analysis showed that mother-to-child transmission rate of HIV was high in
Ethiopia. Being from the rural residence, home delivery, not taking antiretroviral prophylaxis, the absence of
PMTCT intervention, and mixed infant feeding practices increased the risk of HIV transmission.
Trial registration: It is registered in the Prospero database: (PROSPERO 2017: CRD42017078232).
Keywords: HIV-exposed infants, HIV transmission, Infants, Meta-analysis, Mothers, Ethiopia
Background
The pandemics of Human Immunodeficiency Virus (HIV)
have been affecting many segments of the population all over
the world [1]. In 2016, around 36.7 million people lived with
HIV [2]. In sub-Saharan Africa and globally, 110,000 and
160,000 children got new HIV infection respectively [2, 3].
HIV has many routes of transmission including
mother-to-child transmission (MTCT) [4]. More than 90%
of children acquired HIV through MTCT [5, 6], predomin-
antly high in Africa [7]. Studies reported that MTCT rate
during pregnancy or postpartum period was 23% [8] even
though it varies from 15 to 45% in the absence of prophy-
laxis [9]. Between 2009 and 2013, the MTCT rate reduced
from 28 to 18% in sub-Saharan Africa [10].
To control MTCT of HIV as part of end Acquired Im-
munodeficiency Syndrome epidemic strategy [11, 12],
several activities have been inaugurated in Ethiopia.
Ethiopia implemented prevention of mother to child
transmission (PMTCT) intervention since 2001 [13],
such as increasing institutional delivery, Antiretroviral
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coverage, infant prophylaxis, and proper feeding prac-
tices of infants [14, 15].
However, in 2016, 40, 11, and 26% of Ethiopian
women ever screened for HIV, started mixed feeding for
infants before 6 months and delivered at health institu-
tions, respectively [16]. Consequently, MTCT of HIV oc-
curred significantly. Similarly, there were an estimated
14,000 HIV-positive newborns in Ethiopia [17].
Despite many efforts to study the prevalence and risk
factors of MTCT of HIV, there are still fragmented pri-
mary studies in Ethiopia [18–35]. The majority of the
studies showed epidemiologic variations from 0.7% [28]
to 32.0% [19] over time and across geographical areas.
Similarly, a disagreement among those studies about
major factors was observed. Therefore, this systematic
review and meta-analysis aimed to provide a pooled na-
tional estimate of the prevalence of MTCT of HIV and
its associated factors in Ethiopia. The result of this study
may help to guide policy and decision makers in the pre-
vention and control of MTCT of HIV.
Methods
Reporting
The Preferred Reporting Items for Systematic Reviews and
Meta-analyses (PRISMA) guideline [36] was used to report
the result of this systematic review and meta-analyses
(Additional file 1).
Databases and searching strategy
We searched PubMed, Web of Science, Excerpta Medica
Database (EMBASE), Google Scholar and psycEXTRA
databases for all available studies using the following
search terms: “HIV”; “human immunodeficiency virus”;
“AIDS”; “Acquired immunodeficiency syndrome”;
“mother to child”; “mother to infant”; “mother”; “infant”;
“newborn”; “neonate”; “baby”; “child”; “vertical transmis-
sion”; “mother-to-child transmission”; “MTCT”; “trans-
mission”; “PMTCT”; “prevention of mother to child
transmission”; “factors”; “determinants”; “predictors”;
“enablers”; “barriers”; and “Ethiopia”. Search string was
developed using “AND” and “OR” Boolean operators.
An example of the search details for PubMed illustrated
in Additional file 2. Grey literatures were also searched
from Ethiopian’s University (University of Gondar and
Addis Ababa University) research repository online li-
brary. In addition, a manual search of the reference lists
of included articles was performed.
Inclusion and exclusion criteria
The studies were included if they met the following in-
clusion criteria: (1) observational studies, including
cross-sectional, case-control and cohort studies; (2)
studies conducted in Ethiopia; (3) studies that reported
prevalence and/or risk factors; (4) the outcome was
mother-to-child HIV transmission; (4) both published
and unpublished studies at any time; (5) studies used
any HIV diagnosis approach. MTCT of HIV was defined
as the proportion of the number of infants positive for
HIV divided by the total HIV-exposed infants assessed.
The prevalence in cohort studies the cumulative incidence
was considered as prevalence, in which the number of
new HIV infected cases divided by the overall sample size.
Studies focused on the assessment of knowledge, attitude,
and practice of MTCT without the outcome of interest of
this study, program evaluation studies, studies with only
abstracts, case studies, qualitative studies and citations
without full-text were excluded.
Study selection and quality assessment
All retrieved studies were exported to Endnote version 7
(Thomson Reuters, London) reference manager and du-
plicated studies were carefully removed. Two investiga-
tors (AE and AD) independently screened the titles and
abstracts which were followed by a full-text review to
determine the eligibility of each study. The disagreement
was solved by consensus. Two independent reviewers
(AE and SE) have assessed the quality of the studies.
The quality of each article was evaluated using Joanna
Briggs Institute (JBI) quality appraisal criteria adapted
for studies reporting prevalence data, cross-sectional, co-
hort and case-control studies [37]. The following items
were used to appraise cross-sectional studies: (1) inclu-
sion criteria; (2) description of study subject and setting;
(3) valid and reliable measurement of exposure; (4) ob-
jective and standard criteria used; (5) identification of
confounder; (6) strategies to handle confounder; (7) out-
come measurement; and (8) appropriate statistical ana-
lysis. The following items were used for appraising
cohort studies: (1) similarity of groups; (2) similarity of
exposure measurement; (3) validity and reliability of
measurement; (4) identification of confounder; (5) strat-
egies to deal with confounder; (6) appropriateness of
groups/participants at the start of the study; validity and
reliability of outcome measured; (8) sufficiency of follow
up time; (9) completeness of follow-up or descriptions of
reason to loss to follow-up; (10) strategies to address in-
complete follow-up; and (11) appropriateness of statis-
tical analysis. The following items were used for
appraising case-control study: (1) comparable groups; (2)
appropriateness of cases and controls; (3) criteria to
identify cases and controls; (4) standard measurement of
exposure; (5) similarity in measurement of exposure for
cases and controls; (6) handling of confounder; (7) strat-
egies to handle confounder; (8) standard assessment of
outcome; (9) appropriateness of duration for exposure;
and (10) appropriateness of statistical analysis. Studies
considered low risk whenever fitted to 50% and or above
quality assessment checklist criteria’s.
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Data extraction
Two independent reviewers (AE and TD) extracted the
data and cross-checked to ensure consistency. Discrep-
ancies were solved by discussion and repeating the pro-
cedure. Information about the author and year of
publication, study area, study design, sample size, the
prevalence rate of MTCT of HIV and AOR for identified
risk factors were extracted. The reviewer contacted the
corresponding author(s) for further information when-
ever pertinent data were missed from the included
studies.
Data analysis
A weighted inverse variance random-effects model [38]
was used to estimate the overall pooled prevalence. The
pooled AOR of rural residence, home delivery, mixed in-
fant feeding, mothers ARV prophylaxis, PMTCT inter-
vention, and infant ARV prophylaxis. Subgroup analyses
according to the study geographical area and study de-
sign were employed to adjust the variations in the
pooled estimate of the prevalence. The percentage of
total variation across studies due to heterogeneity was
assessed using an I2 statistic [39]. The values of I2 25,
50, and 75% represented low, moderate and high hetero-
geneity respectively [39]. Publication bias across studies
was checked using funnel plot and Egger’s regression
test [40]. STATA version 14 (Stata Corp, College Station,
TX, USA) statistical software was used for all statistical
analysis.
Result
Characteristics of included studies
The search strategy identified 1378 articles from
PubMed, 78 articles from Google Scholar, 17 articles
from psycEXTRA, 13 articles from EMBASE, 4 articles
from Web of Science, 9 articles from Ethiopian’s Univer-
sity research repository online library, and 7 articles
through manual search. First, 65 articles were selected
for full-text review after duplicated (n = 296) and irrele-
vant studies based on the titles and abstracts (n = 1146)
were removed. Then, the full-text review was performed
and 47 articles were excluded for different reasons. Fi-
nally, 18 articles were found relevant to determine the
prevalence and/or associated factors. Fig. 1 has shown
the study selection process.
Among eighteen studies, one case-control [30], seven
cross-sectional [18–20, 24, 27, 29, 35], and ten cohort stud-
ies [21–23, 25, 26, 28, 31–34] were found. Regarding the
geographical area, five studies were conducted in Amhara
region [20, 22–24, 27], five in Oromia [18, 21, 30, 32, 34],
one in Southern Nation Nationalities and People (SNNPR)
[26], six in Addis Ababa [19, 28, 29, 31, 33, 35] and one in
Dire Dawa city [25]. Table 1 shows the characteristics of
those studies.
Quality of the included studies
One study was assessed using JBI checklist for case-control
studies [30], ten studies [21–23, 25, 26, 28, 31–34]
using JBI checklist for cohort studies, and seven studies
[18–20, 24, 27, 29, 35] using the JBI checklist for
cross-sectional studies. None of the studies were excluded
based on the quality assessment criteria (Table 1).
Meta-analysis
Publication bias
Three studies [26–28] were excluded from prevalence es-
timation after checking funnel plot and the significance of
Egger’s regression test. However, they were not excluded
from meta-analysis for risk factors. Significant publication
bias with an Egger’s regression p-value< 0.001 was seen
when all studies considered (Fig. 2a). After adjustment,
Egger’s regression p-value was 0.206, indicated a reduced
publication bias (Fig. 2b).
Qualitative description
Primarily, among eighteen studies, the one was case-control
study was not considered in the prevalence estimation. The
other three studies [26–28] were excluded from the pooled
analysis step-by-step until p-value in the Egger’s regression
test scored greater than 0.05. These studies were: Girma M
[28] report the prevalence of MTCT of HIV was 0.7% in
Addis Ababa whereas Asmamaw et al. [27] reported 3.8% in
Amhara region. In addition, Tadele T et al. [26] found 4.16%
prevalence of MTCT of HIV in SNNPR region.
Prevalence of MTCT of HIV
Consequently, fourteen studies [18–25, 29, 31–35] were in-
cluded in the final meta-analysis. The prevalence of MTCT
of HIV ranges from 5.9% in Amhara region [23] to 32.1% in
Addis Ababa [19]. The pooled prevalence was 11.4% (95%
Confidence Interval) CI = 9.1 to 13.7, I2 = 8.43%; p < 0.001)
(Fig. 3). Egger’s regression test p-value = 0.206.
We performed subgroup analysis by region and study
design. Consequently, MTCT of HIV prevalence was
15.7% in Dire Dawa, 12.34% in Addis Ababa, 11.95% in
Oromia, and 9.56% in Amhara region (Fig. 4).
In addition, the higher prevalence was (13.3%) re-
ported among cohort studies. The detailed results are il-
lustrated in Fig. 5.
Risk factors for MTCT of HIV
Based on the review done associated factors were cate-
gorized into three thematic areas. These were: (1)
socio-demographic, (2) prenatal, intranatal and postna-
tal, and (3) clinical and drugs-related factors.
Socio-demographic related factors
Those children who were born from mothers age greater
than 27 years were more likely (AOR = 5.4, 95% CI =
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Table 1 General characteristics of the included studies
Author/Year Study Area Study design Sample size Prevalence (95% CI) Quality
Moges AN et al./2017 [23] Amhara Retrospective cohort 305 5.9(3.3–8.5) Low risk
Tadele T et al./2014 [26] SNNP Retrospective follow up 457 4.2(2.3–6.0) Low risk
Amare H et al./2014 [19] Addis Ababa Cross-sectional 159 32.1(24.8–39.4) Low risk
Berhan Z et al./2014 [20] Amhara Cross-sectional 434 10.1(7.3–12.9) Low risk
Birlie B et al./2016 [21] Oromia Retrospective follow up 146 17(10.9–23.1) Low risk
Koye DN, Zeleke BM/2013 [22] Amhara Retrospective follow up 509 10(7.4–12.6) Low risk
Wudineh F, Damtew B/ 2016 [25] Dire Dawa Retrospective cohort 382 15.7(12.1–19.3) Low risk
Abdula M/2015 [26] Oromia Cross-sectional 130 7.7(3.1–12.3) Low risk
Asmamaw Y et al./2017 [27] Amhara Cross-sectional 313 3.8(1.7–5.9) Low risk
Tigabu Z, Wasie B/2016 [24] Amhara Cross-sectional 484 12.4(1.5–9.5) Low risk
Girma M/2016 [28] Addis Ababa Prospective cohort 435 0.7(−0.08–1.5) Low risk
Shargie MB et al./2011 [29] Addis Ababa Cross-sectional 118 6.8(2.3–11.3) Low risk
Burusie A, Deyessa N/2015 [30] Oromia Case-control 424 Not applicable Low risk
Mirkuzie AH et al./2010 [31] Addis Abba Retrospective cohort 896 11.8 (9,7–13.9) Low risk
Derebe G et al./2014 [32] Oromia Retrospective cohort 426 9.6 (6.8–12.4) Low risk
Mirkuzie AH et al./2011 [33] Addis Ababa Prospective cohort 71 8.4 (1.9–14.8) Low risk
Kumela K et al./2015 [34] Oromia Retrospective cohort 180 15.5 (10.2–20.8) Low risk
Negash TG, Ehlers VJ/2016 [35] Addis Ababa Cross-sectional 384 6.0 (3.6–11.3) Low risk
Fig. 1 Studies selection process flow chart for the studies included in the analyses
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1.15, 25.70) to acquire HIV infection as compared to
those with less than 27 years [23]. Two studies [22, 25]
reported being rural residence was associated factor of
MTCT of HIV. The pooled AOR of MTCT of HIV in
infant from rural versus urban residence was 3.8 (95%
CI = 1.4 to 6.3, I2 = 0.0%, p = 0.506) (Fig. 6).
Prenatal, Intranatal, and post natal-related factors
Mothers who became pregnant after they knew their
HIV positivity (AOR = 0.22, 95%CI = 0.049, 096) were
less likely to transmit HIV to their infants [23]. Add-
itionally, the rate of HIV infection was higher among
those mothers who knew their HIV sero-positivity
Fig. 2 Funnel plot before adjustment (a) and after adjustment (b) for publication bias, Logprop or LNP (log of proportion) represented in the x-axis
and standard error of log proportion in the y-axis
Fig. 3 Forest plot of the prevalence with corresponding 95% CIs of the fourteen studies on MTCT of HIV. The midpoint and the length of each
segment indicated prevalence and a 95% CI whereas the diamond shape showed the combined prevalence of all studies
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during pregnancy (AOR = 4.71, 95% CI = 1.39–15.93)
and after delivery (AOR = 4.46, 95%CI: 1.40–16.22) as
compared with those who knew before getting preg-
nant [30]. The presence of mothers’ illness during
pregnancy (AOR = 20.4, 95%CI: 3.1–25.7) [26] and ab-
sence of maternal antenatal care visit (AOR = 4.6,
95%CI: 1.17–17.99) [27] were also contributing factors
to MTCT of HIV.
HIV exposed infants who were enrolled in the
follow-up clinic lately (AOR = 2.89, 95% CI: 1.35, 6.21)
were more likely to have HIV infection [22]. A mother
who had cracked nipple and/or mastitis while lactating
(AOR = 13.05, 95%CI: 1.23–138.21) was also found a sig-
nificant predictor [30].
Four studies [21, 22, 24, 25] showed a significant asso-
ciation between place of birth and MTCT of HIV. The
pooled AOR of MTCT of HIV for infants born at home
versus health institution was 3.2 (95% CI = 1.2 to 5.2, I2
= 0.0%, p = 0.906) (Fig. 7). Egger’s regression test was
showed a p-value of 0.055.
Six studies [20–22, 25, 26, 30] showed a significant as-
sociation between infant feeding practice and MTCT of
HIV. The pooled AOR of MTCT of HIV in mixed
feeding versus exclusive breastfeeding practice was 4.3
(95% CI = 1.8 to 6.7, I2 = 0.0%, p = 0.860) (Fig. 7). Egger’s
regression test was showed a p-value of 0.085.
Clinical and drugs-related factors
Delayed HIV diagnosis (AOR = 2.7, 95% CI = 1.3, 29.4)
[20], mothers being on late AIDS stage (AOR = 5.8; 95%
CI: 1.6–16.5) [21], mothers with CD4 cell count < 200
(AOR = 7.65, 95%CI: 3.20–18.31), and 201–500 (AOR =
4. 07, 95%CI: 1.90–8.71) cells/μl during lactation [30]
were found more likely to transmit HIV to their child.
Three studies [21–23] showed a significant association
between PMTCT utilization and MTCT of HIV. The
pooled AOR of MTCT of HIV in infants whose mother
couldn’t get PMTCT intervention was 5.1 (95% CI = 1.6
to 8.6, I2 = 0.0%, p = 0.837) (Fig. 8). Egger’s regression
test was showed a p-value of 0.343.
Five studies [20, 25–27, 30] showed a significant asso-
ciation between mothers on ART prophylaxis during
pregnancy and/or breastfeeding and MTCT of HIV. The
pooled AOR of MTCT of HIV in infants whose mothers
didn’t receive prophylaxis during pregnancy and/or
breastfeeding was 6.1 (95% CI = 2.3 to 9.6, I2 = 42.5%, p
Fig. 4 Forest plot of the prevalence with corresponding 95% CIs of the subgroup analysis based on the regions, where the studies done. The
midpoint and the length of each segment indicated prevalence and a 95% CI whereas the diamond shape showed the combined prevalence
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= 0.138) (Fig. 8). Egger’s regression test was showed a
p-value of 0.204.
Two studies [25, 27] showed a significant association
between infants ART prophylaxis and MTCT of HIV.
The pooled AOR of MTCT of HIV in infants didn’t re-
ceive ARV prophylaxis was 5.8 (95% CI = 1.5 to 10.0, I2
= 0.0%, p = 0.936) (Fig. 8).
Discussion
Our meta-analysis aimed to estimate the pooled preva-
lence of MTCT of HIV and its associated factors in
Ethiopia. In this meta-analysis, the overall pooled preva-
lence rate of MTCT of HIV was 11.4%. In addition, socio-
demographic, natal, and clinical and drug-related factors
were found to be the predictors of MTCT of HIV.
Fig. 6 Forest plot of the adjusted odds ratios with corresponding 95% CIs of studies on the association of rural residence and MTCT of HIV. The
midpoint and the length of each segment indicated an AOR and a 95% CI; the arrow showed the widest CI; and the diamond shape showed the
combined AOR of all studies
Fig. 5 Forest plot of the prevalence with corresponding 95% CIs of the study design. The midpoint and the length of each segment indicated
prevalence and a 95% CI whereas the diamond shape showed the combined prevalence
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The prevalence of MTCT of HIV in the current study
was higher than 2013 United Nations Program on HIV/
AIDS reports in South Africa (6%) and in Botswana (2%)
[41]. Low maternal adherence to antenatal care
utilization, extensive home delivery, less availability and
accessibility of PMTCT interventions and HIV counsel-
ing in remote areas, inconsistent availability of infra-
structures like roads, light and water and prevailing
pre-lacteal feeding habit might cause the higher rate of
MTCT of HIV in Ethiopia. Low level of knowledge and
awareness of mothers about MTCT of HIV might also
attribute to high HIV infection rate among infants in
Ethiopia [42, 43]. Moreover, MTCT of HIV has been
eliminated in some countries, like Cuba, Belarus,
Armenia, and Thailand [44]. This might be due to, in
these countries, minimized of the pregnant women prac-
ticed unprotected sex, women with HIV in those countries
didn’t breastfeed their babies, availability of best suited
safe and healthy alternative baby formula, good attitudes
and perceptions to use HIV drugs during pregnancy, high
level of early HIV test before getting pregnant and/or dur-
ing pregnancy, and persistence implementation of
PMTCT after the infants delivered safely.
Although the current finding showed the high burden,
it is lower than 2013 UNAIDS reports in Burkina Faso
(22%) and in Ethiopia (25%) [41]. The possible reasons
for such discrepancy might be related to year of the
study, and an emerging of new strategies and improve-
ment on HIV prevention and control activities.
The subgroup analysis revealed that there was a sig-
nificant variation among regions. Infants born from
HIV-positive mothers in Amhara region had lower rates
of MTCT of HIV compared to Addis Ababa and Oromia
regions. However, this finding was inconsistent with the
2016 Ethiopia Demographic Health Survey (EDHS) re-
ports in Addis Ababa and Amhara region [16]. This dis-
crepancy might be due to the fact that there might be
the change in the epidemiological transitions of diseases,
on and off interventions as per the prevailing HIV cases,
the difference in HIV-test coverage, and the difference of
awareness to HIV.
According to this study, infants from the rural resi-
dence were nearly four times more likely to acquire HIV
infection from their mothers. This could be due to living
in rural area of Ethiopia, low knowledge to MTCT of
HIV, the high proportion of mothers unaware of their
HIV status, lack of clinic-based education and counsel-
ing [45], lower level of education, belonging to lower
wealth, and not exposed to mass media [46].
In this study, infants delivered at home were nearly
three times more likely to get HIV infection compared
to infants delivered at health institutions. This finding
was in agreement with a study conducted in Nigeria [47]
and Zimbabwe [48]. This could be due to home delivery
Fig. 7 Forest plot of the adjusted odds ratios with corresponding 95% CIs of studies on the association of home delivery and mixed infant
feeding with MTCT of HIV. The midpoint and the length of each segment indicated an AOR and a 95% CI; the arrow showed widest CI; and the
diamond shape showed the combined AOR of all studies for each variable
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lack implementation of HIV prevention strategies as it
does in the health institution. The 90% of HIV-infection
among infants born from seropositive mothers is higher
during labor and delivery [5], particularly in the absence
of integrated HIV services. The previous study [49] in
Africa showed infants who delivered at home were more
prone to many harmful traditional practices that pro-
mote HIV-infection rate, such as cord-cutting by shared
razor, placental blood contamination, uvulectomy, un-
planned circumcision, pre-lacteal feeding, and breast-
feeding from unexamined nipples.
This study also showed that HIV-exposed infants who
didn’t take ARV prophylaxis and whose mothers didn’t re-
ceive prophylaxis during pregnancy and/or breastfeeding
were nearly six times more likely to get HIV-infection.
This finding was in line with a study conducted in
Cote'devore [50], South Africa, and sub-Saharan Africa
[51, 52]. There is also evidence that showed not initiating
ARV prophylaxis to the infant is a risk factor for MTCT
of HIV [53, 54]. This is due to the fact that without ARV
drugs a potential effect of HIV transcription, replication,
and fusion increased in the human body [55]. Besides,
those infants whose mother couldn’t get PMTCT inter-
vention were 5 times more likely to have HIV infection.
This finding was in agreement with studies done in Kenya
[56, 57]. PMTCT strategies are considering prevention of
HIV infection among women, prevention of unwanted
pregnancy, antenatal protection of fetus, test and counsel-
ing of pregnant women, ARV prophylaxis, and treatment
of pregnant women. Therefore, MTCT of HIV could
highly observable among those mothers lacked PMTCT
interventions.
Mixed infant feeding practice also identified as a key
predictor of high rate of MTCT of HIV; infants who re-
ceived mixed feeding were seven times more likely to ac-
quire HIV infection compared to those exclusively
breastfed. This finding agreed with studies in South Africa
[58] and Zimbabwe [59]. Mixed feeding practices may
cause laceration of gastrointestinal mucosa which would
create a favorable entry of the virus into the bloodstream.
MTCT continues to be a devastating clinical and/or
public health burden in Ethiopia. Adequate emphasis
has not been given on this pandemic which might lead
to increased hospitalizations, cost of healthcare services
and reduction of the overall economic structure of the
nation. It could be reduced if all women delivered at
health institutions. To achieve the WHO’s end AIDS
strategy [11], Ethiopia planned to create “HIV-free gen-
eration by the year 2020” [13] and implementing the
health policy that focused on PMTCT and other infec-
tious diseases. However, the burden of MTCT of HIV
remains high in the Ethiopian population. Thus, the
Fig. 8 Forest plot of the adjusted odds ratios with corresponding 95% CIs of studies on the association of absence of mother ARV prophylaxis,
absence of infant ARV prophylaxis, and absence of PMTCT intervention with MTCT of HIV. The midpoint and the length of each segment indicated an
AOR and a 95% CI; the arrow showed widest CI; and the diamond shape showed the combined AOR of all studies for each variable
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finding of this study would be important to develop fur-
ther HIV control interventions and may have a signifi-
cant impact on health service resource utilization. It also
contributes to the growing need for undertaking ART. It
will have direct or indirect importance in providing in-
formation to the Joint United Nations Programme on
HIV/AIDS and partners, 90–90-90 targets; 90% of all
HIV-positive persons identified, provide antiretroviral
therapy (ART) for 90% of those diagnosed, and achieve
viral suppression for 90% of those treated by 2020.
Strength and limitation
This study as it is the first systematic review and
meta-analysis that provided the national prevalence esti-
mate on MTCT of HIV. In addition, the effects of three
key predictors of MTCT of HIV were estimated. On the
other hand, given the limited number of studies, the re-
sult may not represent the national figure. Furthermore,
the time-trend analysis was not conducted because stud-
ies were not available in all the year.
Conclusion
The MTCT rate of HIV was high. Urban residence, home
delivery, not taking antiretroviral prophylaxis, the absence
of PMTCT intervention, and mixed infant feeding prac-
tices were significant predictors of MTCT in Ethiopia.
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